A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-007-0577-6 ◽

2007 ◽

Vol 62 (1) ◽

pp. 77-84 ◽

Author(s):

Jeeyun Lee ◽

Young-Hyuck Im ◽

Eun Yoon Cho ◽

Yong Sang Hong ◽

Hyo Rak Lee ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Line Chemotherapy

Download Full-text

A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2081-5 ◽

2013 ◽

Vol 71 (4) ◽

pp. 905-911 ◽

Author(s):

Jialei Wang ◽

Jianhua Chang ◽

Hui Yu ◽

Xianghua Wu ◽

Huijie Wang ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Metastatic Squamous Cell Carcinoma ◽

Carcinoma Of Esophagus ◽

Line Chemotherapy

Download Full-text

Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study

10.1186/s12885-015-1716-9 ◽

2015 ◽

Vol 15 (1) ◽

Author(s):

Su Jin Lee ◽

Sungmin Kim ◽

Moonjin Kim ◽

Jeeyun Lee ◽

Yeon Hee Park ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma

World Journal of Gastroenterology ◽

10.3748/wjg.v19.i35.5910 ◽

2013 ◽

Vol 19 (35) ◽

pp. 5910 ◽

Author(s):

Yi-Fu He

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Chinese Patients ◽

Line Chemotherapy

Download Full-text

Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study

10.18632/oncotarget.5193 ◽

2015 ◽

Vol 6 (35) ◽

pp. 38429-38439 ◽

Author(s):

Yaping Xu ◽

Yuanda Zheng ◽

Xiaojiang Sun ◽

Xinmin Yu ◽

Jialei Gu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Elderly Patients ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Preliminary Results ◽

Concurrent Radiotherapy

Download Full-text

A randomized phase II study of leucovorin, 5-fluorouracil with or without oxaliplatin (LV5FU2 vs. FOLFOX) for curatively-resected, node-positive esophageal squamous cell carcinoma

Annals of Oncology ◽

10.1093/annonc/mdw371.35 ◽

2016 ◽

Vol 27 ◽

pp. vi218

Author(s):

S.H. Lim ◽

Y.-L. Choi ◽

S.-H. Jung ◽

M.-J.A. Ahn ◽

K. Park ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Node Positive ◽

Randomized Phase Ii ◽

Download Full-text

Nal-iri/lv5-fu versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study

Annals of Oncology ◽

10.1093/annonc/mdz247.168 ◽

2019 ◽

Vol 30 ◽

pp. v324

Author(s):

V. Randrian ◽

A. Adenis ◽

J. Desrame ◽

E. Barbier ◽

F. Di Fiore ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Second Line ◽

Second Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study

Radiation Oncology ◽

10.1186/1748-717x-8-108 ◽

2013 ◽

Vol 8 (1) ◽

pp. 108 ◽

Author(s):

Dongqing Wang ◽

Jiali Yang ◽

Jingyu Zhu ◽

Baosheng Li ◽

Limin Zhai ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Fractionated Radiotherapy ◽

Lymph Node Irradiation

Download Full-text

A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma

International Journal of Clinical Oncology ◽

10.1007/s10147-018-1239-x ◽

2018 ◽

Vol 23 (3) ◽

pp. 466-472 ◽

Author(s):

Shuji Hiramoto ◽

Ken Kato ◽

Hirokazu Shoji ◽

Natsuko Okita ◽

Atsuo Takashima ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Retrospective Analysis ◽

Squamous Cell ◽

Treatment Strategy ◽

Recent Treatment ◽

Line Chemotherapy

Download Full-text

972TiP Phase II study of intratumoral MK-1454 plus pembrolizumab compared with pembrolizumab monotherapy as first-line treatment for metastatic or unresectable, recurrent head and neck squamous cell carcinoma

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1087 ◽

2020 ◽

Vol 31 ◽

pp. S683

Author(s):

K.J. Harrington ◽

W.N. William ◽

A. Khilnani ◽

A.P. Algazi

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Line Treatment ◽

Recurrent Head ◽

First Line Treatment

Download Full-text

126P A phase II study of rh-endostatin combined with irinotecan plus cisplatin as the second-line treatment for advanced esophageal squamous cell carcinoma (ESCC)

Annals of Oncology ◽

10.1016/j.annonc.2020.10.147 ◽

2020 ◽

Vol 31 ◽

pp. S1292

Author(s):

J. Chang ◽

H. Wang ◽

Z. Hu ◽

J. Wang ◽

X. Wu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Line Treatment ◽

Download Full-text